BioXcel Therapeutics
BTAI
$1.18
Share price
-0.84%
Change (1 day)
-93.26%
Change (1 year)
Categories
BioXcel Therapeutics (BTAI) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $0.15 B
According to BioXcel Therapeutics's latest financial reports the company's total liabilities are $0.15 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
BioXcel Therapeutics - Total liabilities on balance sheet (from 2017 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.12 B | 626.3% |
| 2021-12-31 | $17.77 M | 34.23% |
| 2020-12-31 | $13.24 M | 39.41% |
| 2019-12-31 | $9.49 M | 103.8% |
| 2018-12-31 | $4.66 M | 99.4% |
| 2017-12-31 | $2.33 M | 606.04% |
| 2016-12-31 | $0.33 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $22.14 M | -85.69% | 🇺🇸 USA |